BioCardia, Inc. (BCDA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 350K 700K 1.1M Q1 '21: 46K Q2 '21: 69K Q3 '21: 821K Q4 '21: 79K Q1 '22: 60K Q2 '22: 974K Q3 '22: 212K Q4 '22: 106K Q1 '23: 64K Q2 '23: 43K Q3 '23: 357K Q4 '23: 13K Q1 '24: 55K Q2 '24: 3K Q3 '24: 0 Q4 '24: 0 Q1 '25: 0 Q2 '25: 0 Q3 '25: 0 Q4 '25: 0 Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25

Gross Profit Quarterly

0 25K 50K 75K Q1 '10: 0 Q2 '10: 0 Q3 '10: 0 Q4 '10: 0 Q1 '11: 0 Q2 '11: 0 Q3 '11: 0 Q4 '11: 12K Q1 '12: 11K Q2 '12: 17K Q3 '12: 19K Q4 '12: 15K Q1 '13: 38K Q2 '13: 69K Q2 '10 Q4 '10 Q2 '11 Q4 '11 Q2 '12 Q4 '12 Q2 '13

Operating Income Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '21: -2.7M Q4 '21: -3.5M Q1 '22: -3.3M Q2 '22: -2.5M Q3 '22: -3.1M Q4 '22: -3M Q1 '23: -3.5M Q2 '23: -3.5M Q3 '23: -2.6M Q4 '23: -2.1M Q1 '24: -2.3M Q2 '24: -1.6M Q3 '24: -1.8M Q4 '24: -2.3M Q1 '25: -2.7M Q2 '25: -2.1M Q3 '25: -1.5M Q4 '25: -2M Q1 '26: -2.3M Q2 '26: -1.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '21: -2.7M Q4 '21: -3.5M Q1 '22: -3.3M Q2 '22: -2.5M Q3 '22: -3.1M Q4 '22: -3M Q1 '23: -3.5M Q2 '23: -3.4M Q3 '23: -2.6M Q4 '23: -2.1M Q1 '24: -2.3M Q2 '24: -1.6M Q3 '24: -1.7M Q4 '24: -2.3M Q1 '25: -2.7M Q2 '25: -2M Q3 '25: -1.5M Q4 '25: -2M Q1 '26: -2.3M Q2 '26: -1.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 70K 140K 210K Q1 '17: 175K Q2 '17: 203K Q3 '17: 147K Q4 '17: 165K Q1 '18: 157K Q2 '18: 135K Q3 '18: 109K Q4 '18: 116K Q1 '19: 106K Q2 '19: 191K Q3 '19: 24K Q4 '19: 37K Q1 '20: 4K Q2 '20: 0 Q3 '20: 0 Q4 '20: 0 Q1 '21: 0 Q2 '21: 0 Q3 '21: 0 Q4 '21: 0 Q2 '17 Q1 '18 Q4 '18 Q3 '19 Q2 '20 Q1 '21 Q4 '21

Operating Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '21: -2.6M Q4 '21: -3M Q1 '22: -2.9M Q2 '22: -2.6M Q3 '22: -2M Q4 '22: -3M Q1 '23: -2.6M Q2 '23: -3.2M Q3 '23: -2.4M Q4 '23: -1.9M Q1 '24: -1.5M Q2 '24: -1.3M Q3 '24: -2.6M Q4 '24: -2.4M Q1 '25: -1.6M Q2 '25: -1.6M Q3 '25: -1.7M Q4 '25: -2.5M Q1 '26: -1.7M Q2 '26: -1.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '21: -2.7M Q4 '21: -3M Q1 '22: -2.9M Q2 '22: -2.7M Q3 '22: -2M Q4 '22: -3M Q1 '23: -2.6M Q2 '23: -3.2M Q3 '23: -2.4M Q4 '23: -1.9M Q1 '24: -1.5M Q2 '24: -1.3M Q3 '24: -2.6M Q4 '24: -2.4M Q1 '25: -1.6M Q2 '25: -1.6M Q3 '25: -1.7M Q4 '25: -2.5M Q1 '26: -1.7M Q2 '26: -1.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 80M 160M 240M Q1 '16: 230.3M Q2 '16: 230.3M Q3 '16: 230.5M Q1 '21: 16.6M Q2 '21: 17M Q3 '21: 17.1M Q1 '22: 17.1M Q2 '22: 17.7M Q3 '22: 17.8M Q1 '23: 20.2M Q2 '23: 1.4M Q3 '23: 1.4M Q1 '24: 1.7M Q2 '24: 1.9M Q3 '24: 2.8M Q1 '25: 4.6M Q2 '25: 5.1M Q3 '25: 6.3M Q1 '26: 10.8M Q2 '26: 12.1M Q2 '16 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-7.50 -5.00 -2.50 0.00 2.50 5.00 7.50 Q3 '21: -0.69 Q4 '21: -0.75 Q1 '22: -0.76 Q2 '22: -0.70 Q3 '22: -0.71 Q4 '22: -0.66 Q1 '23: -0.64 Q2 '23: -3.02 Q3 '23: -4.64 Q4 '23: -5.80 Q1 '24: -6.98 Q2 '24: -5.34 Q3 '24: -4.16 Q4 '24: -3.09 Q1 '25: -2.33 Q2 '25: -1.85 Q3 '25: -1.48 Q4 '25: -1.29 Q1 '26: -0.91 Q2 '26: -0.64 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.